A Potent Autophagy Inhibitor (Lys05) Enhances the Impact of Ionizing Radiation on Human Lung Cancer Cells H1299
Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
Grantová podpora
Q40/06 and Q40/09
PROGRES
P50 CA174523
NCI NIH HHS - United States
P30 CA016520
NCI NIH HHS - United States
P01 CA114046
NCI NIH HHS - United States
SV/FVZ201501
Ministry of Defence of the Czech Republic and Ministry of Education, Youth and Sports of the Czech Republic
PubMed
31771188
PubMed Central
PMC6928878
DOI
10.3390/ijms20235881
PII: ijms20235881
Knihovny.cz E-zdroje
- Klíčová slova
- Lys05, autophagy, cancer, ionizing radiation, non-small cell lung carcinoma,
- MeSH
- apoptóza účinky záření MeSH
- fluorescenční mikroskopie MeSH
- ionizující záření * MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nádory plic metabolismus MeSH
- průtoková cytometrie MeSH
- transmisní elektronová mikroskopie MeSH
- western blotting MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Autophagy inhibition through small-molecule inhibitors is one of the approaches to increase the efficiency of radiotherapy in oncological patients. A new inhibitor-Lys05-with the potential to accumulate within lysosomes and to block autophagy was discovered a few years ago. Several studies have addressed its chemosensitizing effects but nothing is known about its impact in the context of ionizing radiation (IR). To describe its role in radiosensitization, we employed radioresistant human non-small cell lung carcinoma cells (H1299, p53-negative). Combined treatment of H1299 cells by Lys05 together with IR decreased cell survival in the clonogenic assay and real-time monitoring of cell growth more than either Lys05 or IR alone. Immunodetection of LC3 and p62/SQSTM1 indicated that autophagy was inhibited, which correlated with increased SQSTM1 and decreased BNIP3 gene expression determined by qRT-PCR. Fluorescence microscopy and flow cytometry uncovered an accumulation of lysosomes. Similarly, transmission electron microscopy demonstrated the accumulation of autophagosomes confirming the ability of Lys05 to potentiate autophagy inhibition in H1299 cells. We report here for the first time that Lys05 could be utilized in combination with IR as a promising future strategy in the eradication of lung cancer cells.
Zobrazit více v PubMed
Farhat F.S., Houhou W. Targeted therapies in non-small cell lung carcinoma: What have we achieved so far? Ther. Adv. Med. Oncol. 2013;5:249–270. doi: 10.1177/1758834013492001. PubMed DOI PMC
Yu L., Shang Z.-F., Hsu F.-M., Zhang Z., Tumati V., Lin Y.-F., Chen B.P.C., Saha D. NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor. Oncotarget. 2015;6:3848–3860. doi: 10.18632/oncotarget.2975. PubMed DOI PMC
Levine B., Klionsky D.J. Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev. Cell. 2004;6:463–477. doi: 10.1016/S1534-5807(04)00099-1. PubMed DOI
Ondrej M., Cechakova L., Durisova K., Pejchal J., Tichy A. To live or let die: Unclear task of autophagy in the radiosensitization battle. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 2016;119:265–275. doi: 10.1016/j.radonc.2016.02.028. PubMed DOI
McAfee Q., Zhang Z., Samanta A., Levi S.M., Ma X.-H., Piao S., Lynch J.P., Uehara T., Sepulveda A.R., Davis L.E., et al. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc. Natl. Acad. Sci. USA. 2012;109:8253–8258. doi: 10.1073/pnas.1118193109. PubMed DOI PMC
Yamamoto A., Tagawa Y., Yoshimori T., Moriyama Y., Masaki R., Tashiro Y. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 1998;23:33–42. doi: 10.1247/csf.23.33. PubMed DOI
Shao S., Li S., Qin Y., Wang X., Yang Y., Bai H., Zhou L., Zhao C., Wang C. Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia. Int. J. Oncol. 2014;44:1661–1668. doi: 10.3892/ijo.2014.2313. PubMed DOI PMC
Horie R., Nakamura O., Yamagami Y., Mori M., Nishimura H., Fukuoka N., Yamamoto T. Apoptosis and antitumor effects induced by the combination of an mTOR inhibitor and an autophagy inhibitor in human osteosarcoma MG63 cells. Int. J. Oncol. 2016;48:37–44. doi: 10.3892/ijo.2015.3227. PubMed DOI PMC
Park J.M., Tougeron D., Huang S., Okamoto K., Sinicrope F.A. Beclin 1 and UVRAG confer protection from radiation-induced DNA damage and maintain centrosome stability in colorectal cancer cells. PLoS ONE. 2014;9:e100819. PubMed PMC
Dowling C.M., Herranz Ors C., Kiely P.A. Using real-time impedance-based assays to monitor the effects of fibroblast-derived media on the adhesion, proliferation, migration and invasion of colon cancer cells. Biosci. Rep. 2014;34:e00126. doi: 10.1042/BSR20140031. PubMed DOI PMC
Limame R., Wouters A., Pauwels B., Fransen E., Peeters M., Lardon F., De Wever O., Pauwels P. Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS ONE. 2012;7:e46536. doi: 10.1371/journal.pone.0046536. PubMed DOI PMC
Chou T.-C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70:440–446. doi: 10.1158/0008-5472.CAN-09-1947. PubMed DOI
Hernández J.L., Padilla L., Dakhel S., Coll T., Hervas R., Adan J., Masa M., Mitjans F., Martinez J.M., Coma S., et al. Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody. PLoS ONE. 2013;8:e72480. doi: 10.1371/journal.pone.0072480. PubMed DOI PMC
Mizushima N., Yoshimori T. How to interpret LC3 immunoblotting. Autophagy. 2007;3:542–545. doi: 10.4161/auto.4600. PubMed DOI
Bjørkøy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., Stenmark H., Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 2005;171:603–614. doi: 10.1083/jcb.200507002. PubMed DOI PMC
Zhang J., Zhang C., Jiang X., Li L., Zhang D., Tang D., Yan T., Zhang Q., Yuan H., Jia J., et al. Involvement of autophagy in hypoxia-BNIP3 signaling to promote epidermal keratinocyte migration. Cell Death Dis. 2019;10:234. doi: 10.1038/s41419-019-1473-9. PubMed DOI PMC
Manic G., Obrist F., Kroemer G., Vitale I., Galluzzi L. Chloroquine and hydroxychloroquine for cancer therapy. Mol. Cell. Oncol. 2014;1:e29911. doi: 10.4161/mco.29911. PubMed DOI PMC
Toulany M., Mihatsch J., Holler M., Chaachouay H., Rodemann H.P. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 2014;111:228–236. doi: 10.1016/j.radonc.2014.04.001. PubMed DOI
Karagounis I.V., Kalamida D., Mitrakas A., Pouliliou S., Liousia M.V., Giatromanolaki A., Koukourakis M.I. Repression of the autophagic response sensitises lung cancer cells to radiation and chemotherapy. Br. J. Cancer. 2016;115:312–321. doi: 10.1038/bjc.2016.202. PubMed DOI PMC
Amaravadi R.K., Winkler J.D. Lys05: A new lysosomal autophagy inhibitor. Autophagy. 2012;8:1383–1384. doi: 10.4161/auto.20958. PubMed DOI PMC
Koukourakis M.I., Kalamida D., Mitrakas A., Pouliliou S., Kalamida S., Sivridis E., Giatromanolaki A. Intensified autophagy compromises the efficacy of radiotherapy against prostate cancer. Biochem. Biophys. Res. Commun. 2015;461:268–274. doi: 10.1016/j.bbrc.2015.04.014. PubMed DOI
Cheng G., Kong D., Hou X., Liang B., He M., Liang N., Ma S., Liu X. The tumor suppressor, p53, contributes to radiosensitivity of lung cancer cells by regulating autophagy and apoptosis. Cancer Biother. Radiopharm. 2013;28:153–159. doi: 10.1089/cbr.2012.1297. PubMed DOI PMC
Apel A., Herr I., Schwarz H., Rodemann H.P., Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res. 2008;68:1485–1494. doi: 10.1158/0008-5472.CAN-07-0562. PubMed DOI
Hanna R.A., Quinsay M.N., Orogo A.M., Giang K., Rikka S., Gustafsson Å.B. Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J. Biol. Chem. 2012;287:19094–19104. doi: 10.1074/jbc.M111.322933. PubMed DOI PMC
Huang Z., Ye B., Dai Z., Wu X., Lu Z., Shan P., Huang W. Curcumin inhibits autophagy and apoptosis in hypoxia/reoxygenation-induced myocytes. Mol. Med. Rep. 2015;11:4678–4684. doi: 10.3892/mmr.2015.3322. PubMed DOI
Tanida I. Autophagy basics. Microbiol. Immunol. 2011;55:1–11. doi: 10.1111/j.1348-0421.2010.00271.x. PubMed DOI
Tanida I., Minematsu-Ikeguchi N., Ueno T., Kominami E. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy. 2005;1:84–91. doi: 10.4161/auto.1.2.1697. PubMed DOI
Mizushima N., Yamamoto A., Hatano M., Kobayashi Y., Kabeya Y., Suzuki K., Tokuhisa T., Ohsumi Y., Yoshimori T. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J. Cell Biol. 2001;152:657–668. doi: 10.1083/jcb.152.4.657. PubMed DOI PMC
Mizushima N., Ohsumi Y., Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct. Funct. 2002;27:421–429. doi: 10.1247/csf.27.421. PubMed DOI
Makowska A., Eble M., Prescher K., Hoß M., Kontny U. Chloroquine Sensitizes Nasopharyngeal Carcinoma Cells but Not Nasoepithelial Cells to Irradiation by Blocking Autophagy. PLoS ONE. 2016;11:e0166766. doi: 10.1371/journal.pone.0166766. PubMed DOI PMC
Lu S., Sung T., Lin N., Abraham R.T., Jessen B.A. Lysosomal adaptation: How cells respond to lysosomotropic compounds. PLoS ONE. 2017;12:e0173771. doi: 10.1371/journal.pone.0173771. PubMed DOI PMC
Chikte S., Panchal N., Warnes G. Use of LysoTracker dyes: A flow cytometric study of autophagy. Cytom. Part. J. Int. Soc. Anal. Cytol. 2014;85:169–178. doi: 10.1002/cyto.a.22312. PubMed DOI
Gade T.P.F., Tucker E., Nakazawa M.S., Hunt S.J., Wong W., Krock B., Weber C.N., Nadolski G.J., Clark T.W.I., Soulen M.C., et al. Ischemia Induces Quiescence and Autophagy Dependence in Hepatocellular Carcinoma. Radiology. 2017;283:702–710. doi: 10.1148/radiol.2017160728. PubMed DOI PMC
Ndoye A., Budina-Kolomets A., Kugel C.H., Webster M.R., Kaur A., Behera R., Rebecca V.W., Li L., Brafford P.A., Liu Q., et al. ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma. Cancer Res. 2017;77:5873–5885. doi: 10.1158/0008-5472.CAN-17-0907. PubMed DOI PMC
DeVorkin L., Hattersley M., Kim P., Ries J., Spowart J., Anglesio M.S., Levi S.M., Huntsman D.G., Amaravadi R.K., Winkler J.D., et al. Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian Carcinoma. Mol. Cancer Res. MCR. 2017;15:250–258. doi: 10.1158/1541-7786.MCR-16-0132. PubMed DOI PMC
Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. PubMed DOI
The Effect of Chronic Exposure of Graphene Nanoplates on the Viability and Motility of A549 Cells